Well, thank you for having me, it's a privilege to be part of this panel with these amazing researchers and women. Just a quick framing note, I was an advisor to the campaign, I'm not an advisor to the administration to the current administration, which in many ways the work you have to do not knowing what might be happening as vaccines are set to receive, you know, authorization from the FDA, and we don't quite know what the plans to roll them out might be what the discourse about them. Now, availability of vaccines might be debt, made the campaign have to contemplate a lot of scenarios, some have not come to pass and some were facing them right now. So I can speak a little bit to dad and then I can you know, as a scholar, and as a policy, and law person, I can talk about some of the present challenges we're now seeing surface here. Part of it goes to some of the issues that we've already touched on the idea that there's a preceding epidemic, so there's the virus at the root of COVID-19. But vaccine misinformation and disinformation precedes that epidemic and just before COVID, we were seeing attrition in the rights of vaccination in the US and elsewhere. Where we're also seeing I think, as that epidemic grew and grew, even before COVID, we were seeing something that I think is positive. And I know that members of the campaign and the administration are aware of, which is the fact that we now have very granular data on what acts and misinformation now looks like. Part of it because of the work of people like john wick explained it to was part of it, because of what you just mentioned, that we understand the anti vaccine or vaccine questioning networks operate, we know that COVID has maximize the reach of those networks, we know exactly how many accounts that have been labeled as anti Vax, for instance, have been added by each one of the mainstream networks, we even suspect or have some pretty reliable math on, for instance, monetization of anti vaccine content associated with accounts that tend to thrive on different types of health misinformation, complicating things, having a look at different pathways towards the dissemination of anti vaccine content. So we have all these data to build on. And I think that's a tool that we were not as aware of before, up until 2018. And this is information that the administration certainly works on up until 2018. We had very little information on for instance, Russia centered efforts to promote vaccine misinformation, it turns out, they send accurate and inaccurate information our way at the same time just to increase devices. Now, it doesn't really matter to the senders that it's vaccine specific. It's just a tool, it's been instrumentalized. So the problem is bigger. The tools that we have, and particularly the data that we now have, and this is an administration that relies on science and on data are much better. So you've seen specific proposals, House Democrats have proposed a multi agency commission, for instance, or task force, that would look broadly at misinformation issues, and certainly COVID-19 related misinformation issues would be at the center of that. This strikes me as a really good, good idea. And I have two points to make. One is related to this. And it's this idea that we may be talking about vaccine misinformation. But it's not an environment that's restricted to vaccines, things that have happened elsewhere, in the COVID pandemic, for instance, involving the FDA, and some of this horses that were made about emergency use authorizations of products that have nothing to do with vaccines, but there was some overstating of data. So some things that damage some institutional reputation, that the current administration is now seeking to repair. I think this points to extensive damage. And I think the idea of understanding vaccine misinformation is being about health misinformation. And about even more than that is crucial. And then on the other hand, again, not taking off my advisory hat, but the legal scholar one and me, I would just, you know, conclude this person's revention by saying, from a legal perspective, from a policy perspective, there's a number of things we can do. And they can range from nudging certain behaviors being more better at communicating at different levels from federal level to local level. And then there are what I would call a nuclear nuclear option, say we want to regulate this very stringently and strictly, and they might be on the table, the administration is aware of some of those options, but just because we can be extremely stringent, it doesn't necessarily mean we should, sometimes reaching for some form of compromise and be being more dialectic, I think, is a better option than, again, posing certain acts that will be construed as paternalistic, or government or government influenced and influenced and ultimately might backfire in addressing.